Healthcare -
Biotechnology - NASDAQ - US
$ 18.76
-0.875 %
$ 1.89 B
Market Cap
-3.69
P/E
BEAM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BEAM - Beam Therapeutics Inc.
7.74 M
LAST VALUE
-73.67%
2 YEAR CAGR
-28.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR